Followers | 839 |
Posts | 120502 |
Boards Moderated | 18 |
Alias Born | 09/05/2002 |
Tuesday, October 10, 2017 2:03:50 PM
[Updated to indicate that M710 is probably Xolair.]
Copaxone program
• 2017(?): Expected FDA approval of NVS/MNTA’s 40mg-Copaxone ANDA. On 2/17/17, MNTA reported that the ANDA approval was held up due to an FDA compliance issue at PFE’s fill/finish facility, which NVS/MNTA are using for Glatopa (#msg-128816545). Approval probably can’t happen until PFE fixes all compliance issued at this site.
FoB program
• 4Q17: Submit 351(k) FDA application for M923 (Humira FoB), which is wholly owned by MNTA.
• Timing unknown: M923 commercial partnership or out-license.
• 2H17: Report phase-1 data for M934 (Orencia FoB), the lead FoB compound in the MYL-MNTA partnership (#msg-126247535). The phase-1 trial started in Nov 2016 (#msg-126247535).
• 4Q17: CAFC hearing on BMY’s Orencia patent. (MNTA appealed the USPTO’s IPR decision in favor of BMY to the CAFC, which granted expedited review.)
• Late 2017/early 2018: File IND for M710 (the second FoB compound in the MYL-MNTA partnership) and formally disclose what the compound is. M710 is likely Xolair (#msg-135286163).
Proprietary autoimmune program
• 4Q17: Report data from SAD and MAD portions of phase-1 trial of M281, an anti-FcRn mAb wholly owned by MNTA.
• 4Q17: Start phase-1 trial of M230, an Fc-receptor compound partnered with CSL (#msg-127656306).
• 2018 Start phase-1 trial of M254, a hyper-sialylated IVIG.
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM